PepGen Revenue and Competitors
Estimated Revenue & Valuation
- PepGen's estimated annual revenue is currently $13.8M per year.
- PepGen's estimated revenue per employee is $155,000
Employee Data
- PepGen has 89 Employees.
- PepGen grew their employee count by 25% last year.
PepGen's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Staff | Reveal Email/Phone |
2 | VP, Bioanalytical, Biomarkers and DMPK | Reveal Email/Phone |
3 | Head Corporate Strategy and Business Development | Reveal Email/Phone |
4 | VP, Global Regulatory Affairs | Reveal Email/Phone |
5 | SVP | Reveal Email/Phone |
6 | VP Clinical Science | Reveal Email/Phone |
7 | VP, Quality Assurance | Reveal Email/Phone |
8 | VP, Finance & Controller | Reveal Email/Phone |
9 | SVP Strategy & Operations | Reveal Email/Phone |
10 | SVP Chemistry & Manufacturing | Reveal Email/Phone |
PepGen Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is PepGen?
N/A
Total Funding
89
Number of Employees
$13.8M
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
PepGen News
2022-04-17 - PepGen Targets IPO For Duchenne Muscular Dystrophy Treatments
PepGen has filed to raise funding via a U.S. IPO. The firm is developing treatment candidates for Duchenne Muscular Dystrophy and related...
2022-03-30 - PepGen Announces First Participant Dosed in a Phase 1 ...
PepGen Announces First Participant Dosed in a Phase 1 Clinical Trial of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy.
2022-03-22 - PepGen Continues to Build Leadership Team with Additions ...
BOSTON, March 30, 2022 (GLOBE NEWSWIRE) -- PepGen, Inc., advancing the next generation of oligonucleotide therapies with the goal of...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $12.9M | 89 | 9% | N/A |
#2 | $24M | 89 | 5% | N/A |
#3 | N/A | 89 | 9% | N/A |
#4 | $15M | 89 | 3% | N/A |
#5 | $31.4M | 89 | 22% | N/A |